Swiftmerge Acquisition Cost of Goods Sold 1970-1969 | ANNA

Swiftmerge Acquisition cost of goods sold from 1970 to 1969. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Swiftmerge Acquisition Annual Cost of Goods Sold
(Millions of US $)
Swiftmerge Acquisition Quarterly Cost of Goods Sold
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.042B $0.000B
Swiftmerge Acquisition Corp. entered into definitive merger agreement with HDL Therapeutics Inc.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00